Literature DB >> 19898964

Biotransformation of celecoxib using microbial cultures.

Keshetty Srisailam1, Ciddi Veeresham.   

Abstract

Microbial transformation studies can be used as models to simulate mammalian drug metabolism. In the present investigation, biotransformation of celecoxib was studied in microbial cultures. Bacterial, fungal, and yeast cultures were employed in the present study to elucidate the metabolism of celecoxib. The results indicate that a number of microorganisms metabolized celecoxib to various levels to yield eight metabolites, which were identified by high-performance liquid chromatography diode array detection and liquid chromatography tandem mass spectrometry analyses. HPLC analysis of biotransformed products indicated that majority of the metabolites are more polar than the substrate celecoxib. The major metabolite was found to be hydroxymethyl metabolite of celecoxib, while the remaining metabolites were produced by carboxylation, methylation, acetylation, or combination of these reactions. The methyl hydroxylation and further conversion to carboxylic acid was known to occur in metabolism by mammals. The results further support the use of microorganisms for simulating mammalian metabolism of drugs.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898964     DOI: 10.1007/s12010-009-8789-3

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  6 in total

1.  Antimicrobial and antioxidant activities and chemical profiling of Curvularia tsudae endophytic in Cynodon dactylon (L.) Pers.

Authors:  R Nischitha; M M Vasanthkumari; B E Kumaraswamy; M B Shivanna
Journal:  3 Biotech       Date:  2020-06-11       Impact factor: 2.406

2.  Celecoxib does not alter intestinal microbiome in a longitudinal diet-controlled study.

Authors:  N A Bokulich; T Battaglia; J O Aleman; J M Walker; M J Blaser; P R Holt
Journal:  Clin Microbiol Infect       Date:  2016-01-22       Impact factor: 8.067

3.  In Vitro Biotransformation, Safety, and Chemopreventive Action of Novel 8-Methoxy-Purine-2,6-Dione Derivatives.

Authors:  Małgorzata Anna Marć; Enrique Domínguez-Álvarez; Karolina Słoczyńska; Paweł Żmudzki; Grażyna Chłoń-Rzepa; Elżbieta Pękala
Journal:  Appl Biochem Biotechnol       Date:  2017-06-17       Impact factor: 2.926

4.  Enantioselective Resolution of (R,S)-Carvedilol to (S)-(-)-Carvedilol by Biocatalysts.

Authors:  Swetha Ettireddy; Vijitha Chandupatla; Ciddi Veeresham
Journal:  Nat Prod Bioprospect       Date:  2017-01-07

5.  Short-term supplementation of celecoxib-shifted butyrate production on a simulated model of the gut microbial ecosystem and ameliorated in vitro inflammation.

Authors:  Emma Hernandez-Sanabria; Evelien Heiremans; Marta Calatayud Arroyo; Ruben Props; Laurent Leclercq; Jan Snoeys; Tom Van de Wiele
Journal:  NPJ Biofilms Microbiomes       Date:  2020-02-19       Impact factor: 7.290

6.  Cunninghamella as a microbiological model for metabolism of histamine H(3) receptor antagonist 1-[3-(4-tert-butylphenoxy)propyl]piperidine.

Authors:  Elżbieta Pękala; Paulina Kubowicz; Dorota Łażewska
Journal:  Appl Biochem Biotechnol       Date:  2012-09-16       Impact factor: 2.926

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.